Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Treace Medical Concepts (TMCI) Interest & Investment Income (2020 - 2025)

Historic Interest & Investment Income for Treace Medical Concepts (TMCI) over the last 6 years, with Q3 2025 value amounting to $634000.0.

  • Treace Medical Concepts' Interest & Investment Income fell 4058.11% to $634000.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $3.1 million, marking a year-over-year decrease of 4462.81%. This contributed to the annual value of $4.9 million for FY2024, which is 2749.03% down from last year.
  • Latest data reveals that Treace Medical Concepts reported Interest & Investment Income of $634000.0 as of Q3 2025, which was down 4058.11% from $775000.0 recorded in Q2 2025.
  • Treace Medical Concepts' Interest & Investment Income's 5-year high stood at $2.0 million during Q2 2023, with a 5-year trough of -$1000.0 in Q1 2021.
  • Moreover, its 5-year median value for Interest & Investment Income was $775000.0 (2025), whereas its average is $799000.0.
  • In the last 5 years, Treace Medical Concepts' Interest & Investment Income tumbled by 10303.03% in 2021 and then surged by 1633333.33% in 2023.
  • Quarter analysis of 5 years shows Treace Medical Concepts' Interest & Investment Income stood at $5000.0 in 2021, then soared by 14960.0% to $753000.0 in 2022, then soared by 126.96% to $1.7 million in 2023, then tumbled by 47.4% to $899000.0 in 2024, then decreased by 29.48% to $634000.0 in 2025.
  • Its last three reported values are $634000.0 in Q3 2025, $775000.0 for Q2 2025, and $841000.0 during Q1 2025.